文献速递甲状腺疾病

NIFTP 在 Bethesda 甲状腺细胞病理报告系统下的细胞学诊断:系统综述与荟萃分析

Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
PubMed 文献 · Thyroid · 2018-12-21

该系统综述与荟萃分析依据 PRISMA 指南检索 PubMed/MEDLINE 和 Scopus(截至 2018 年 6 月),纳入 15 项回顾性研究、共 915 例组织学证实的 NIFTP,汇总其细针穿刺细胞学按 Bethesda 系统的分类分布。结果显示多数病例细胞学为不确定类别,其余可为非诊断、良性或恶性,提示 NIFTP 缺乏特异性细胞学诊断类别。

要点

  • NIFTP 细胞学多归为 Bethesda 不确定类别,无特异性诊断分类。
  • 915 例 NIFTP 中 AUS/FLUS 占 30%、FN/SFN 占 21%、可疑恶性占 24%。
  • NIFTP 细胞学可呈非诊断、良性或恶性等广泛谱系,研究间轻度异质。

核心结论

  • NIFTP 的细针穿刺细胞学诊断谱广泛,多数为细胞学不确定类别。
  • 其余病例可被判为非诊断、良性或恶性,需进一步细胞学和/或分子特征以实现术前准确诊断。

研究设计与样本

  • 按 PRISMA 指南开展的系统综述与荟萃分析,检索 PubMed/MEDLINE 和 Scopus 至 2018 年 6 月。
  • 纳入 15 项回顾性原始研究,共 915 例组织学证实的 NIFTP,均按 Bethesda 系统报告细胞学结果。

主要发现

  • NIFTP 细胞学 Bethesda 分类分布:非诊断 3%、良性 10%、AUS/FLUS 30%、FN/SFN 21%、可疑恶性 24%、恶性 8%。
  • 研究间存在轻度异质性,未发现发表偏倚。

关键数值与推荐

  • Bethesda 分类占比:非诊断 3%、良性 10%、AUS/FLUS 30%、FN/SFN 21%、可疑恶性 24%、恶性 8%(915 例 NIFTP)。

临床怎么用

  • 对细胞学不确定(AUS/FLUS、FN/SFN)或可疑恶性的甲状腺结节,应考虑到 NIFTP 可能。
  • NIFTP 术前细胞学无法特异识别,需结合细胞学和/或分子特征进一步评估。

局限性

  • 纳入研究均为回顾性研究。
  • 研究间存在轻度异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The recent introduction of noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) in the World Health Organization classification of thyroid tumors has significantly modified the risk of malignancy of cytological diagnoses. In fact, while this tumor was previously classified as a carcinoma (the encapsulated, noninvasive form follicular variant of papillary thyroid carcinoma), it is now considered a neoplasm with low malignant potential. Given that the cytological features of NIFTP are not specific and overlap with other pathologic entities, there is no specific cytological diagnostic category for NIFTP. To obtain more robust information about the cytological findings associated with NIFTP, published articles were systematically reviewed, and a meta-analysis of the data was conducted. METHODS: The review was conducted according to PRISMA guidelines. A comprehensive literature search of the PubMed/MEDLINE and Scopus databases was conducted using a combination of terms "noninvasive," "encapsulated," "follicular variant," "NIFTP," and "thyroid cancer." The search was updated to June 2018, and references of the retrieved articles were also screened. Only original articles reporting the classification of histologically proven NIFTPs with cytological findings according to The Bethesda System for Reporting Thyroid Cytopathology were eligible for inclusion. RESULTS: The literature search revealed 117 articles, of which 15 were included in the study. All studies were retrospective. A total of 915 NIFTP cases were retrieved. The incidence of cases cytologically classified according to the Bethesda system was as follows: non-diagnostic 3%, benign 10%, atypia of undetermined significance or follicular lesion of undetermined significance 30%, follicular neoplasm or suspicious for a follicular neoplasm 21%, suspicious for malignancy 24%, and malignant 8%. Mild heterogeneity between the studies was found. Publication bias was absent. CONCLUSIONS: This meta-analysis shows that the cytological diagnoses associated with NIFTP by fine-needle aspiration cytology includes a wide spectrum of findings. The majority of cases are cytologically indeterminate, and the remainder may be read as non-diagnostic, benign, or malignant. In order to develop an accurate presurgical diagnosis of these cases, further cytological and/or molecular characteristics need to be identified.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Bongiovanni M, Giovanella L, Romanelli F, et al. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis. Thyroid. 2018. PMID: 30426887. doi:10.1089/thy.2018.0394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。